|
Aug 28
|
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
|
|
Aug 28
|
Soleno wins FDA priority review for Prader-Willi therapy
|
|
Aug 28
|
Soleno Therapeutics, Inc. (SLNO): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
|
Aug 27
|
Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
|
|
Aug 7
|
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
|
|
Jul 29
|
When Can We Expect A Profit From Soleno Therapeutics, Inc. (NASDAQ:SLNO)?
|
|
May 15
|
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
|
|
May 9
|
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
|
May 8
|
While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
|
|
May 3
|
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
|
|
May 2
|
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
|
|
Apr 30
|
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
|
|
Apr 29
|
Why Soleno Therapeutics Stock Is Skyrocketing Today
|
|
Apr 29
|
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
|
|
Apr 4
|
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
|
|
Apr 4
|
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
|
|
Mar 11
|
We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn
|
|
Mar 6
|
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
|
|
Feb 14
|
Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Jan 10
|
Here's What Could Help Soleno Therapeutics, Inc. (SLNO) Maintain Its Recent Price Strength
|